Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Receivables (2017 - 2025)

Historic Receivables for Selectis Health (GBCS) over the last 11 years, with Q3 2025 value amounting to $3.2 million.

  • Selectis Health's Receivables rose 6773.2% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 6773.2%. This contributed to the annual value of $3.3 million for FY2024, which is 1431.84% up from last year.
  • According to the latest figures from Q3 2025, Selectis Health's Receivables is $3.2 million, which was up 6773.2% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Selectis Health's Receivables registered a high of $5.2 million during Q2 2022, and its lowest value of $1.8 million during Q1 2024.
  • Moreover, its 5-year median value for Receivables was $3.0 million (2025), whereas its average is $3.1 million.
  • As far as peak fluctuations go, Selectis Health's Receivables surged by 13317.69% in 2021, and later plummeted by 5016.35% in 2023.
  • Quarter analysis of 5 years shows Selectis Health's Receivables stood at $4.4 million in 2021, then fell by 10.53% to $3.9 million in 2022, then dropped by 25.36% to $2.9 million in 2023, then grew by 14.32% to $3.3 million in 2024, then fell by 4.03% to $3.2 million in 2025.
  • Its Receivables was $3.2 million in Q3 2025, compared to $3.0 million in Q2 2025 and $2.9 million in Q1 2025.